A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...
Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...
Medpage Today on MSN18 小时
FDA Plans to Ban Popular Cold Med
The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) ...
Clenbuterol is a drug used in some countries as a bronchodilator to make breathing easier but is perhaps better known as a banned performance-enhancing drug (PDE) used by bodybuilders and athletes to ...
released a list of prescription drugs it hopes to include in its new Medicare $2 Drug List Model, the agency announced Wednesday. Designed to limit out-of-pocket costs, the plan caps a generic ...
is widely available from several drug manufacturers at a fraction of the cost. Read on to find out more about this cheaper Viagra alternative and whether it’s as effective as the brand-name drug.
This number is expected to climb to a staggering 2.1 billion by 2050. This aging population is particularly susceptible to chronic respiratory conditions, leading to an increased need for inhalation ...
The drug was administered twice-daily using a ... phosphodiesterase 3 and 4 (PDE3 and PDE4), and is thought to combine bronchodilator and anti-inflammatory properties in one compound.